Gadolinium-Enhanced Cardiovascular Magnetic Resonance: Administered Dose in Relationship to United States Food and Drug Administration (FDA) Guidelines

Journal of Cardiovascular Magnetic Resonance - United Kingdom
doi 10.1186/1532-429x-14-18

Related search